Horizon Pharma to buy Raptor Pharma for $800 million

September 12, 2016 11:54 AM

5 0

Horizon Pharma Plc (HZNP.O) said it has agreed to buy Raptor Pharmaceutical Corp (RPTP.O) for nearly $800 million to strengthen its portfolio of rare disease drugs.

The specialty pharmaceutical company said it would offer $9 per Raptor share, which is a 21 percent premium to Raptor's Friday close.

Also read: Ant Financial to Invest $200 Million in South Korea’s Kakao Pay

Read more

To category page